These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36253005)

  • 1. Correspondence on "Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer" by Polen-De et al.
    Maccio A; Madeddu C
    Int J Gynecol Cancer; 2022 Nov; 32(11):1493. PubMed ID: 36253005
    [No Abstract]   [Full Text] [Related]  

  • 2. Correspondence on "European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery" by Fotopoulou et al.
    Chandra R; Ray M
    Int J Gynecol Cancer; 2021 Dec; 31(12):1618. PubMed ID: 34686532
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to: Correspondence on "Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer" by Maccio and Madeddu.
    Kumar A; Polen-De C
    Int J Gynecol Cancer; 2022 Nov; 32(11):1494. PubMed ID: 36253003
    [No Abstract]   [Full Text] [Related]  

  • 4. Pre-operative core muscle index in combination with hypoalbuminemia is associated with poor prognosis in advanced ovarian cancer.
    Conrad LB; Awdeh H; Acosta-Torres S; Conrad SA; Bailey AA; Miller DS; Lea JS
    J Surg Oncol; 2018 Apr; 117(5):1020-1028. PubMed ID: 29409111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
    Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J
    Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgery for advanced stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Ferron G; Narducci F; Pouget N; Touboul C
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):197-213. PubMed ID: 30792175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients triaged to neoadjuvant chemotherapy have higher rates of sarcopenia: An opportunity for prehabilitation.
    Fadadu PP; Polen-De CL; McGree ME; Weaver AL; Moynagh MR; Takahashi N; Langstraat CL; Cliby WA; Kumar A
    Gynecol Oncol; 2021 Jan; 160(1):40-44. PubMed ID: 33109391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper abdominal debulking surgery for ovarian cancer total colectomy, total peritonectomy, and extended upper abdominal debulking surgery.
    Taskiran C; Vatansever D; Giray B; Eraslan A; Tanju S; Arvas M; Balik E
    Int J Gynecol Cancer; 2020 Oct; 30(10):1648-1649. PubMed ID: 32948641
    [No Abstract]   [Full Text] [Related]  

  • 9. Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4.
    Lof P; van de Vrie R; Korse CM; van Driel WJ; van Gent MDJM; Karlsen MA; Amant F; Lok CAR
    Int J Gynecol Cancer; 2019 Oct; 29(8):1304-1310. PubMed ID: 31515411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correspondence on 'The Cukurova score in the prediction of primary cytoreduction in ovarian cancer' by Khatib et al.
    Verit FF; Bese T
    Int J Gynecol Cancer; 2024 May; 34(5):797. PubMed ID: 38453179
    [No Abstract]   [Full Text] [Related]  

  • 11. When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer.
    Brown J; Drury L; Crane EK; Anderson WE; Tait DL; Higgins RV; Naumann RW
    J Minim Invasive Gynecol; 2019; 26(5):902-909. PubMed ID: 30240899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy.
    Abitbol J; Gotlieb W; Zeng Z; Ramanakumar A; Kessous R; Kogan L; Pare-Miron V; Rombaldi M; Salvador S; Kucukyazici B; Brin S; How J; Lau S
    Int J Gynecol Cancer; 2019 Nov; 29(9):1341-1347. PubMed ID: 31601648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery.
    Ataseven B; Luengo TG; du Bois A; Waltering KU; Traut A; Heitz F; Alesina PF; Prader S; Meier B; Schneider S; Koch JA; Walz M; Groeben HT; Nina P; Brunkhorst V; Heikaus S; Harter P
    Ann Surg Oncol; 2018 Oct; 25(11):3372-3379. PubMed ID: 30069659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive validity of American College of Surgeons: National Surgical Quality Improvement Project risk calculator in patients with ovarian cancer undergoing interval debulking surgery.
    Manning-Geist B; Cathcart AM; Sullivan MW; Pelletier A; Cham S; Muto MG; Del Carmen M; Growdon WB; Sisodia RC; Berkowitz R; Worley M
    Int J Gynecol Cancer; 2021 Oct; 31(10):1356-1362. PubMed ID: 34518239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy.
    Maheshwari A; Kumar N; Gupta S; Rekhi B; Shylasree TS; Dusane R; Bajpai J; Ghosh J; Gulia S; Deodhar K; Menon S; Popat P; Sable N; Thakur M; Kerkar R
    Indian J Cancer; 2018; 55(1):50-54. PubMed ID: 30147093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery.
    Rutten IJ; Ubachs J; Kruitwagen RF; van Dijk DP; Beets-Tan RG; Massuger LF; Olde Damink SW; Van Gorp T
    Eur J Surg Oncol; 2017 Apr; 43(4):717-724. PubMed ID: 28159443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cardiophrenic lymph node removal in advanced ovarian cancer.
    Boria F; Chiva L
    Int J Gynecol Cancer; 2021 Feb; 31(2):307. PubMed ID: 33273019
    [No Abstract]   [Full Text] [Related]  

  • 18. In Reference to Jonsdottir B et al. "The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer".
    Carboni F; Valle M
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):956-957. PubMed ID: 32748149
    [No Abstract]   [Full Text] [Related]  

  • 19. Laparoscopic management of advanced epithelial ovarian cancer after neoadjuvant chemotherapy: a phase II prospective multicenter non-randomized trial (the CILOVE study).
    Pomel C; Akladios C; Lambaudie E; Rouzier R; Ferron G; Lecuru F; Classe JM; Fourchotte V; Paillocher N; Wattiez A; Montoriol PF; Thivat E; Beguinot M; Canis M
    Int J Gynecol Cancer; 2021 Dec; 31(12):1572-1578. PubMed ID: 34670829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging before cytoreductive surgery in advanced ovarian cancer patients.
    Rizzo S; Del Grande M; Manganaro L; Papadia A; Del Grande F
    Int J Gynecol Cancer; 2020 Jan; 30(1):133-138. PubMed ID: 31754068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.